According to Medifast's latest financial reports the company's current EPS (TTM) is $15.92. In 2022 the company made an earnings per share (EPS) of $16.70 a decrease over its 2021 EPS that were of $18.28.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $16.66 | -0.2% |
2022 | $16.70 | -8.63% |
2021 | $18.28 | 60.41% |
2020 | $11.39 | 32.02% |
2019 | $8.63 | 42.06% |
2018 | $6.07 | 100% |
2017 | $3.04 | 54.3% |
2016 | $1.97 | -9.04% |
2015 | $2.16 | 66% |
2014 | $1.30 | -42.53% |
2013 | $2.27 | 50% |
2012 | $1.51 | -12.12% |
2011 | $1.72 | -5.71% |
2010 | $1.82 | 66.67% |
2009 | $1.09 | 127.03% |
2008 | $0.48 | 23.33% |
2007 | $0.39 | -18.92% |
2006 | $0.48 | 68.18% |
2005 | $0.29 | 37.5% |
2004 | $0.21 | -36% |
2003 | $0.33 | -30.56% |
2002 | $0.47 | 350% |
2001 | $0.10 | -57.89% |
2000 | $0.25 |